BKBurcu Kesikli

Burcu Kesikli

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Burcu Kesikli has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of dietary inflammatory index and dietary antioxidant capacity with maternal inflammatory and oxidative markers in preeclampsia

    by Iclal Sena Gezer, Ayse Gulcin Bastemur, Atakan Tanacan, Cigdem Karagoz, Burcu Kesikli, Ozgur Kara, Dilek Sahin, Nuray Yazihan

  • Open Access

    Relation of inflammatory and oxidative biomarkers associated with relapse in pregnant women diagnosed with multiple sclerosis

    by Burcu Bozkurt Özdal, Ayşe Gülçin Baştemur, İcLal Sena Gezer, Burcu Kesikli, Ersin Kasım Ulusoy, Atakan Tanaçan, Nuray Yazıhan, Dilek Şahin

    SUMMARY OBJECTIVE: The aim of this study was to examine the relationship between inflammatory mediators (tumor necrosis factor-alpha, interleukin-6, and interleukin-10), oxidative stress parameters, and obstetric-neonatal outcomes in maternal blood of pregnant patients with multiple sclerosis and healthy pregnant patients, and to identify biomarkers that may be useful in predicting relapse in pregnant patients with multiple sclerosis. METHODS: This prospective, single-center study was conducted at Ankara City Hospital between July 2024 and May 2025 and included a total of 72 patients: 36 pregnant women diagnosed with multiple sclerosis and 36 healthy pregnant women as the control group. The patients with multiple sclerosis were further divided into two groups: those who experienced relapses during pregnancy and those who did not. Clinical and demographic data, biochemical tests (interleukin-6, interleukin-10, tumor necrosis factor-alpha, total antioxidant status, and total oxidant status), and obstetric and neonatal outcomes were recorded. Data were analyzed statistically using SPSS 22.0, and appropriate statistical tests and correlation analyses were applied. RESULTS: Levels of interleukin-6, interleukin-10, tumor necrosis factor-alpha, total oxidant status, and total antioxidant status were significantly higher in patients with multiple sclerosis compared to controls (p<0.01). These parameters were even more elevated in patients who experienced relapses. Receiver operating characteristic analysis demonstrated that cut-off values of 237.8 pg/mL for tumor necrosis factor-alpha and 1.75 for interleukin-6/interleukin-10 provided high sensitivity and specificity in predicting multiple sclerosis relapse. CONCLUSION: Inflammatory and oxidative stress markers were elevated in pregnant women with multiple sclerosis, and tumor necrosis factor-alpha levels and the interleukin-6/interleukin-10 ratio were identified as potential biomarkers for predicting disease relapse.

  • Open Access

    The influence of dietary choices: investigation of the relationship dietary inflammatory index and fetal growth restriction

    by Ayşe Gülçin Baştemur, İcLal Sena Gezer, Burcu Kesikli, Atakan Tanaçan, Özgür Kara, Nuray Yazıhan, Dilek Şahin

    Fetal growth restriction (FGR) is characterized by the fetus’s inability to reach its growth potential and affecting approximately 10% of the population. The etiology of late-onset FGR, which occurs after 32 weeks, is unclear but may be influenced by maternal weight. A proinflammatory diet can cause chronic inflammation and, Dietary Inflammatory Index (DII) was developed to evaluate of the diet’s impact on inflammation. A high DII indicates a pro-inflammatory diet, known to increase serum inflammatory markers, with oxidative stress playing a key role in inflammatory diseases. The study aimed to investigate the correlation between maternal DII, total oxidant status (TOS), total antioxidant status (TAS), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor-alpha (TNF-α) levels in FGR-diagnosed pregnant women. This prospective-observational study included FGR-diagnosed pregnant women and healthy pregnant women with gestational ages of 32–38 weeks (n = 23 per group). Chronic diseases, hypertension, fetal anomalies, membrane ruptures, and multiple pregnancies were excluded. The DII was calculated using the BeBiS-9 program based on 3-day dietary records kept by an expert dietician. Blood samples were collected, centrifuged, and analyzed for IL-6, TNF-α, IL-10, TAS, and TOS. The study group had significantly higher DII scores (p < 0.001), lower energy (p = 0.004), carbohydrate (p = 0.002), protein (p = 0.011), fiber (p < 0.001) intake than the control group. TNF-α levels were elevated in the FGR group (p < 0.001), while IL-6 levels were higher but not statistically significant (p = 0.06). IL-10 levels were lower in the study group (p = 0.05). TAS, TOS, and TAS/TOS levels showed no significant differences between groups. Logistic regression indicated a 62% increase in FGR probability with higher DII levels (p = 0.001, CI 1.209–2.195). Correlation analysis revealed a strong positive correlation between DII and maternal serum TNF-α (r = 0.375, p = 0.01) and a strong negative correlation between birth weight and TNF-α (r=-0.478, p < 0.001) and DII (r=-0.446, p = 0.002). This study showed that a pro-inflammatory maternal diet increased dietary inflammatory index and increased maternal inflammatory markers, and this was more significant in fetuses with FGR than in normal weight fetuses.


  • Effect of ascorbic acid on collagen and some inflammatory mediators in rats

    by Sibel Işin, Nuray Yazihan, Burcu Kesi̇kli̇, Derya Bi̇ri̇ken, Sevginur Akdaş, Ferda Topal Celi̇kkan, Batuhan Bakirarar, Pelin Aribal-Ayral

    Musculoskeletal injuries as a kind of traumas that the human body is exposed to, adversely affect the quality of life and workforce of individuals due to restriction of movement function. This study was aimed to evaluate the effects of dose-dependent ascorbic acid administration on the repair process after gastrocnemius muscle injury in rats. In this study, 5-month-old 66 male Wistar Albino rats were used and rats were randomized to 6 groups (n = 11/group). A linear incision was made in the gastrocnemius muscle of thirty-three animals included in the muscle injury groups. Ascorbic acid (5-10 mg/kg/day) was administered to the four groups intraperitoneally just after surgery once a day. Animals were sacrificed twenty-one days later. Blood and tissue samples were used for cytokine, collagen, and histological measurements. It was found that ascorbic acid reduced serum IL-6 and muscle tissue TNF-α levels, and increased liver tissue IL-10 levels. Muscle tissue collagen levels were not statistically different between the groups in parallel with our histological results. In our study, it was demonstrated that vitamin C has effects on inflammatory mediators during muscle tissue repair to explain mechanism detailed molecular analyzes are needed.


  • Open Access

    Maternal selenium status plays a crucial role on clinical outcomes of pregnant women with COVID‐19 infection

    by Seyit Ahmet Erol, Naci Polat, Sevginur Akdas, Pelin Aribal Ayral, Ali Taner Anuk, Eda Ozden Tokalioglu, Şule Goncu Ayhan, Burcu Kesikli, Merve Nur Ceylan, Atakan Tanacan, et al.

    Adequate maternal selenium level is essential for immune response and healthy pregnancy. This study aimed to shed light on the selenium status of pregnant women with COVID‐19 and the effects of potential deficiency in serum selenium levels. Totally 141 pregnant women, 71 of them were COVID‐19 patients, in different trimesters were included in the study. Maternal serum selenium levels, demographic and clinical parameters were determined. Serum selenium levels of pregnant women in the second (p: .0003) and third (p: .001) trimesters with COVID‐19 were significantly lower than in the healthy group. Maternal selenium level was found to be negatively correlated with gestational week (p < .0001, r: −.541), D‐dimer (p: .0002, r: −.363) and interleukin‐6 (IL‐6) level (p: .02, r: −.243). In the second trimester, serum selenium level positively correlated with white blood cell (p: .002, r: .424), neutrophil (p: .006, r: .39), lymphocyte (p: .004, r: .410) count and hemoglobin (p: .02, r: .323), hematocrit (p: .008, r: .38) status. In the third trimester, it was found that maternal selenium level positively correlated with monocyte (p: .04, r: .353) and negatively correlated with C‐reactive protein level (p: .03, r: −.384). Serum selenium level was gradually decreased during the pregnancy period, however, this natural decrease was enhanced together with COVID‐19 infection. The reason might be increased selenium needs depended on the immune response against infection. The decrease in maternal selenium level was found to be related to IL‐6 and D‐dimer levels, which indicate selenium's role in disease progression.